journal article·2020-12-14Open access

Silk Nanoparticle Manufacture in Semi-Batch Format

Saphia A. L. Matthew, John D. Totten, Suttinee Phuagkhaopong, Gemma Egan, Kimia Witte, Yvonne Perrie, F. Philipp Seib

Abstract

Silk nanoparticles have demonstrated utility across a range of biomedical applications, especially as drug delivery vehicles. Their fabrication by bottom-up methods such as nanoprecipitation, rather than top-down manufacture, can improve critical nanoparticle quality attributes. Here, we establish a simple semi-batch method using drop-by-drop nanoprecipitation at the lab scale that reduces special-cause variation and improves mixing efficiency. The stirring rate was an important parameter affecting nanoparticle size and yield (400 < 200 < 0 rpm), while the initial dropping height (5.5 vs 7.5 cm) directly affected nanoparticle yield. Varying the nanoparticle standing time in the mother liquor between 0 and 24 h did not significantly affect nanoparticle physicochemical properties, indicating that steric and charge stabilizations result in high-energy barriers for nanoparticle growth. Manufacture across all tested formulations achieved nanoparticles between 104 and 134 nm in size with high β-sheet content, spherical morphology, and stability in aqueous media for over 1 month at 4 °C. This semi-automated drop-by-drop, semi-batch silk desolvation offers an accessible, higher-throughput platform for standardization of parameters that are difficult to control using manual methodologies.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Silk-based biomaterials and applications · Phytochemical compounds biological activities · Nanofabrication and Lithography Techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow G4 0RE, U.K.

EPSRC Future Manufacturing Research Hub for Continuous Manufacturing and Advanced Crystallisation (CMAC), University of Strathclyde, Technology and Innovation Centre, 99 George Street, Glasgow G1 1RD, U.K.

Leibniz Institute of Polymer Research Dresden, Max Bergmann Center of Biomaterials Dresden, Hohe Strasse 6, 01069 Dresden, Germany

Funding

Engineering and Physical Sciences Research Council · Medical Research Scotland · Royal Government of Thailand Scholarship

References (58)

Show source-provided references
1. 10.1002/adhm.20180046510.1002/adhm.201800465 ↗
2. 10.1021/acsabm.9b0057610.1021/acsabm.9b00576 ↗
3. 10.1016/j.jconrel.2010.11.00710.1016/j.jconrel.2010.11.007 ↗
4. 10.1021/acsbiomaterials.8b0156010.1021/acsbiomaterials.8b01560 ↗
5. 10.1016/j.actbio.2019.11.05010.1016/j.actbio.2019.11.050 ↗
6. 10.3934/bioeng.2017.2.23910.3934/bioeng.2017.2.239 ↗
7. 10.1016/j.nano.2017.07.01210.1016/j.nano.2017.07.012 ↗
8. 10.1021/acs.biomac.5b0100310.1021/acs.biomac.5b01003 ↗
9. Sofregen. Sofregen Receives 510(k) Clearance for Silk Voice https://www.sofregen.com/press-release-3/press-release-3 (accessed May 1, 2020).
10. 10.1021/acsbiomaterials.6b0045710.1021/acsbiomaterials.6b00457 ↗
11. 10.1016/j.msec.2018.11.01010.1016/j.msec.2018.11.010 ↗
12. 10.1007/s42242-019-00052-910.1007/s42242-019-00052-9 ↗
13. 10.3791/5466910.3791/54669 ↗
14. 10.1002/adhm.20130003410.1002/adhm.201300034 ↗
15. 10.1080/10837450.2018.154523610.1080/10837450.2018.1545236 ↗
16. 10.1080/1061186X.2017.136321210.1080/1061186X.2017.1363212 ↗
17. 10.1021/acsbiomaterials.7b0102110.1021/acsbiomaterials.7b01021 ↗
18. 10.1039/C7SM01631J10.1039/C7SM01631J ↗
19. 10.2147/IJN.S558110.2147/IJN.S5581 ↗
20. 10.1021/acsbiomaterials.0c0020210.1021/acsbiomaterials.0c00202 ↗
21. 10.3390/ijms1603488010.3390/ijms16034880 ↗
22. 10.1007/s11051-010-9965-710.1007/s11051-010-9965-7 ↗
23. 10.1126/sciadv.aay795210.1126/sciadv.aay7952 ↗
24. 10.1002/app.4170210.1002/app.41702 ↗
25. 10.1016/j.ijpharm.2017.01.06710.1016/j.ijpharm.2017.01.067 ↗
26. 10.1007/s11095-008-9800-310.1007/s11095-008-9800-3 ↗
27. 10.1016/j.cocis.2016.03.00310.1016/j.cocis.2016.03.003 ↗
28. 10.1016/0923-0467(95)02982-610.1016/0923-0467(95)02982-6 ↗
29. 10.1007/s00397-013-0723-510.1007/s00397-013-0723-5 ↗
30. 10.1039/C6RA28626G10.1039/C6RA28626G ↗
31. 10.1021/acs.langmuir.8b0065210.1021/acs.langmuir.8b00652 ↗
32. 10.1039/C8NA00208H10.1039/C8NA00208H ↗
33. 10.1038/nprot.2015.02410.1038/nprot.2015.024 ↗
34. 10.1038/ncomms1590210.1038/ncomms15902 ↗
35. 10.1021/ma061010910.1021/ma0610109 ↗
36. Griebenow K. · Internet J. Vib. Spectrosc. · 1999 · 3 · 1
37. 10.1023/A:101150561727410.1023/A:1011505617274 ↗
38. Menczel J. D. · 200910.1002/9780470423837 ↗
39. 10.1016/j.jconrel.2015.03.02010.1016/j.jconrel.2015.03.020 ↗
40. 10.1038/s41563-019-0566-210.1038/s41563-019-0566-2 ↗
41. 10.1016/j.drudis.2018.01.04710.1016/j.drudis.2018.01.047 ↗
42. 10.2217/nnm.12.310.2217/nnm.12.3 ↗
43. 10.22159/ijap.2018v10i5.2813910.22159/ijap.2018v10i5.28139 ↗
44. 10.1007/s11051-006-9162-x10.1007/s11051-006-9162-x ↗
45. 10.1038/s41467-020-17167-810.1038/s41467-020-17167-8 ↗
46. 10.1002/btm2.1000310.1002/btm2.10003 ↗
47. 10.1016/j.ijpharm.2013.08.07910.1016/j.ijpharm.2013.08.079 ↗
48. 10.1016/j.colsurfa.2012.07.02210.1016/j.colsurfa.2012.07.022 ↗
49. 10.1016/j.msec.2017.06.00410.1016/j.msec.2017.06.004 ↗
50. 10.1016/j.ijpharm.2009.12.05210.1016/j.ijpharm.2009.12.052 ↗
51. 10.1016/S0006-3495(00)76668-910.1016/S0006-3495(00)76668-9 ↗
52. 10.1016/j.nantod.2016.04.00310.1016/j.nantod.2016.04.003 ↗
53. 10.1016/j.colsurfb.2014.09.02810.1016/j.colsurfb.2014.09.028 ↗
54. Gao G. · 2011
55. 10.1002/1521-3935(200207)203:10/11<1658::AID-MACP1658>3.0.CO;2-310.1002/1521-3935(200207)203:10/11<1658::AID-MACP1658>3.0.CO;2-3 ↗
56. 10.1016/S0141-8130(01)00159-310.1016/S0141-8130(01)00159-3 ↗
57. 10.1021/cr400544s10.1021/cr400544s ↗
58. 10.1016/j.biomaterials.2011.10.06310.1016/j.biomaterials.2011.10.063 ↗